Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-031703

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 26, 2018 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 20, 2018S32,300$12.2531D1,824,360ISee Footnote
Common StockF1,F3Dec 20, 2018S630$12.2531D1,823,730ISee Footnote
Common StockF1,F4Dec 20, 2018S221$12.2531D1,823,509ISee Footnote
Common StockF1,F5Dec 20, 2018S323$12.2531D1,823,186ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses